Want to see IN:KRONOX full AI Analyst Report?
Kronox Lab Sciences Limited (KRONOX) Ratios
Kronox Lab Sciences Limited Ratios
IN:KRONOX's free cash flow for Q1 2025 was $0.00. For the 2025 fiscal year, IN:KRONOX's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 25 | Mar 24 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 7.60 | 0.00 | 7.28 | 0.00 | 0.00 |
| Quick Ratio | 6.80 | 0.00 | 6.55 | 0.00 | 0.00 |
| Cash Ratio | 0.26 | 0.00 | 0.35 | 0.00 | 0.00 |
| Solvency Ratio | 2.61 | 0.00 | 3.08 | 0.00 | 0.00 |
| Operating Cash Flow Ratio | 2.30 | 0.00 | 3.53 | 0.00 | 0.00 |
| Short-Term Operating Cash Flow Coverage | 39.62 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 674.48M | $ 0.00 | $ 545.85M | $ 0.00 | $ 0.00 |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.10 | 0.00 | 1.10 | 0.00 | 0.00 |
| Debt Service Coverage Ratio | 41.59 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 282.66 | 0.00 | 0.00 | 220.44 | 44.24 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.47 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | -0.03 | 0.00 | -0.09 | 0.00 | 0.00 |
| Profitability Margins | |||||
| Gross Profit Margin | 53.99% | 48.97% | 49.18% | 42.58% | 42.37% |
| EBIT Margin | 36.97% | 31.84% | 34.20% | 23.46% | 22.81% |
| EBITDA Margin | 38.99% | 33.27% | 35.58% | 25.02% | 25.28% |
| Operating Profit Margin | 31.83% | 30.46% | 32.13% | 21.45% | 21.78% |
| Pretax Profit Margin | 36.85% | 31.84% | 34.20% | 23.36% | 22.32% |
| Net Profit Margin | 27.33% | 23.76% | 25.42% | 17.39% | 16.57% |
| Continuous Operations Profit Margin | 27.33% | 23.76% | 25.42% | 17.38% | 16.57% |
| Net Income Per EBT | 74.15% | 74.63% | 74.31% | 74.43% | 74.24% |
| EBT Per EBIT | 115.77% | 104.51% | 106.45% | 108.90% | 102.44% |
| Return on Assets (ROA) | 21.69% | 0.00% | 25.77% | 0.00% | 0.00% |
| Return on Equity (ROE) | 23.82% | 0.00% | 28.26% | 0.00% | 0.00% |
| Return on Capital Employed (ROCE) | 27.50% | 0.00% | 35.72% | 0.00% | 0.00% |
| Return on Invested Capital (ROIC) | 20.29% | 0.00% | 26.54% | 0.00% | 0.00% |
| Return on Tangible Assets | 21.69% | 0.00% | 25.77% | 0.00% | 0.00% |
| Earnings Yield | 6.53% | 3.61% | 4.72% | 2.81% | 2.31% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.78 | 0.00 | 4.92 | 0.00 | 0.00 |
| Payables Turnover | 7.08 | 0.00 | 7.00 | 0.00 | 0.00 |
| Inventory Turnover | 5.56 | 0.00 | 7.99 | 0.00 | 0.00 |
| Fixed Asset Turnover | 3.42 | 0.00 | 3.50 | 0.00 | 0.00 |
| Asset Turnover | 0.79 | 0.00 | 1.01 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 1.64 | 0.00 | 2.14 | 0.00 | 0.00 |
| Cash Conversion Cycle | 90.41 | 0.00 | 67.68 | 0.00 | 0.00 |
| Days of Sales Outstanding | 76.39 | 0.00 | 74.16 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 65.59 | 0.00 | 45.67 | 0.00 | 0.00 |
| Days of Payables Outstanding | 51.57 | 0.00 | 52.16 | 0.00 | 0.00 |
| Operating Cycle | 141.99 | 0.00 | 119.83 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 6.46 | 0.00 | 8.27 | 0.00 | 0.00 |
| Free Cash Flow Per Share | 5.57 | 0.00 | 7.44 | 0.00 | 0.00 |
| Dividend Paid and CapEx Coverage Ratio | 4.63 | 0.00 | 6.19 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 7.22 | 0.00 | 9.89 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | 14.87 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.24 | 0.00 | 0.31 | 0.00 | 0.00 |
| Free Cash Flow Yield | 4.86% | 0.00% | 5.11% | 0.00% | 0.00% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 15.32 | 27.69 | 21.07 | 35.57 | 43.38 |
| Price-to-Sales (P/S) Ratio | 4.19 | 6.58 | 5.39 | 6.18 | 7.19 |
| Price-to-Book (P/B) Ratio | 3.65 | 0.00 | 5.99 | 0.00 | 0.00 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 20.58 | 0.00 | 19.58 | 0.00 | 0.00 |
| Price-to-Operating Cash Flow Ratio | 17.73 | 0.00 | 17.60 | 0.00 | 0.00 |
| Price-to-Earnings Growth (PEG) Ratio | 1.86 | 0.98 | 1.04 | 1.61 | 0.00 |
| Enterprise Value Multiple | 10.71 | 0.00 | 15.06 | 0.00 | 0.00 |
| Enterprise Value | 4.22B | 0 | 5.37B | 0 | 0 |
| EV to EBITDA | 10.71 | 0.00 | 15.06 | 0.00 | 0.00 |
| EV to Sales | 4.17 | 0.00 | 5.36 | 0.00 | 0.00 |
| EV to Free Cash Flow | 20.52 | 0.00 | 19.47 | 0.00 | 0.00 |
| EV to Operating Cash Flow | 17.68 | 0.00 | 17.50 | 0.00 | 0.00 |
| Tangible Book Value Per Share | 31.42 | 0.00 | 24.28 | 0.00 | 0.00 |
| Shareholders’ Equity Per Share | 31.42 | 0.00 | 24.28 | 0.00 | 0.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.26 | 0.25 | 0.26 | 0.26 | 0.26 |
| Revenue Per Share | 27.39 | 24.22 | 27.00 | 25.76 | 22.17 |
| Net Income Per Share | 7.48 | 5.75 | 6.86 | 4.48 | 3.67 |
| Tax Burden | 0.74 | 0.75 | 0.74 | 0.74 | 0.74 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 | 0.98 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.01 | 0.06 | 0.01 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.64 | 0.00 | 0.90 | 0.00 | 0.00 |
Currency in INR
